Bruker Corporation's next confirmed earnings release is scheduled for November 4, 2026.
| Earnings Date | 11/4/2026 |
As of June 30, 2026, Bruker Corporation has 152.35M shares outstanding.
| Shares Outstanding | 152.35M |
As of June 30, 2026, Bruker Corporation maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 74.92, indicating elevated leverage, while an interest coverage ratio of 3.24 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.85 |
| Quick Ratio | 0.83 |
| Debt / Equity | 74.92 |
| Debt / EBITDA | 9.15 |
| Interest Coverage | 3.24 |
Over the twelve months ended June 30, 2026, Bruker Corporation posted a negative return on equity (ROE) of -5.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.15, reflecting losses generated across the asset base. The company generates approximately 5.48M in revenue per employee across its workforce of 11,162.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.60 indicates how many times Bruker Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -5.11 |
| Return on Assets (ROA) | -1.15 |
| Revenue Per Employee | 5.48M |
| Employee Count | 11,162.75 |
| Inventory Turnover | 1.60 |
Over the twelve months ended June 30, 2026, Bruker Corporation recorded 705.85M in income tax expense. The company reported a pretax loss of -391.36M and -1.24B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 705.85M |
As of the close on September 14, 2026, Bruker Corporation's stock has declined approximately 33.91% over the past 52 weeks.
| 52-Week Price Change | -33.91% |
Over the twelve months ended June 30, 2026, Bruker Corporation generated 61.14B in revenue and converted that into -1.24B in net income, yielding earnings per share of -7.40. EBITDA reached 3.49B, while operating income came in at 4.65B.
| Revenue | 61.14B |
| Gross Profit | 28.38B |
| Operating Income | 4.65B |
| Pretax Income | -391.36M |
| Net Income | -1.24B |
| EBITDA | 3.49B |
| EBIT | -534.63M |
| Earnings Per Share (EPS) | -7.40 |
As of June 30, 2026, Bruker Corporation holds 3.89B in cash and equivalents against 31.88B in total debt, resulting in a net debt position of 28.65B. Total book value stands at 41.61B, with working capital of 17.83B providing operational flexibility.
| Cash & Cash Equivalents | 3.89B |
| Total Debt | 31.88B |
| Net Debt | 28.65B |
| Equity (Book Value) | 41.61B |
| Book Value Per Share | 273.10 |
| Working Capital | 17.83B |
Bruker Corporation produced 3.33B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.69B in capital expenditures, free cash flow totaled 1.64B - equivalent to 10.79 per share.
| Operating Cash Flow | 3.33B |
| Capital Expenditures | -1.69B |
| Free Cash Flow | 1.64B |
| FCF Per Share | 10.79 |
Over the twelve months ended June 30, 2026, Bruker Corporation posted a gross margin of 46.42, reflecting its pricing power and cost economics. The operating margin of 7.60 and net profit margin of -2.03 provide insight into operational efficiency.
| Gross Margin | 46.42 |
| Operating Margin | 7.60 |
| Pretax Margin | -0.64 |
| Profit Margin | -2.03 |
| EBITDA Margin | 5.70 |
Over the twelve months ended June 30, 2026, Bruker Corporation paid dividends of 6.28 per share. The dividend payout ratio of -20.32 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.
| Dividend Per Share | 6.28 |
| Payout Ratio | -20.32 |